Oral Tolerance: Mechanisms and Therapy of Autoimmune Diseases

Annals of the Academy of Medicine Singapore

Volumn 27, Issue 1, 1998, Pages 47-53

  Koh, D R ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Active suppression; Clonal deletion; Mucosal immunity; Multiple sclerosis; Rheumatoid arthritis

Indexed keywords

AUTOANTIGEN;

ANIMAL; AUTOIMMUNE DISEASE; CLINICAL TRIAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; MOUSE; MOUTH MUCOSA; ORAL DRUG ADMINISTRATION; RAT; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MICE; MOUTH MUCOSA; RATS; TREATMENT OUTCOME;

EID: 0031639664     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Scott D W. Multiple mechanisms of immunologic tolerance: novel approaches for unresponsiveness. Adv Exp Med Biol 1995; 386:209-20.
2. Sarzoth M. Immunologic tolerance. Curr Opin Hematol 1997; 4:48-52.
3. Wells H. Studies on the chemistry of anaphylaxis. III Experiments with isolated proteins, especially those of hen egg. J Infect Dis 1911; 9:147-51.
4. Chase M W. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 1946; 61:257-9.
5. Mowat A M The regulation of immune responses to dietary protein antigens Immunol Today 1987; 8:93-8.
6. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson C O. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 1994; 152:4663-70.
7. Weiner H L, Fnedman A, Miller A, Khoury S J, Al-Sabbagh A, Santos L, et al. Oral tolerance. Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens Annu Rev Immunol 1994; 12:809-37
8. Brandtzaeg P. Overview of the mucosal immune system. Curr Top Mierobiol Immunol 1989; 146:13-25.
9. Husby S, Jensenius J C, Svehag S E. Passage of undegraded dietary antigen into the blood of health adults. Further characterisation of the kinetics of uptake and the size distribution of antigens. Scand J Immunol 1986; 24:447-52.
10. Bruce M G, Ferguson A. The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice Immunology 1986; 59:295-300.
11. Strobel S Neonatal oral tolerance. Ann NY Acad Sci 1996; 778:88-102
12. Whitacre C C, Gienapp I E, Orosz C G, Bitar D M. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991; 147:2155-63.
13. Gregerson D S, Obritsch W F, Donoso L A. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993, 151:5751-61.
14. Friedman A, Weiner H L. Induction of anergy of active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994; 91 6688-92.
15. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo V K, Weiner H L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376:177-80.
16. Van-Houten N, Blake S F Direct measurement of anergy of antigen-specific T cells following oral tolerance induction J Immunol 1996; 157:1337-41.
17. Santos L M, al-Sabbagh A, Londono A, Weiner H L Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Cell Immunol 1994; 157-439-47.
18. Chen Y, Kuchroo V K, Inobe J, Hafler D A, Weiner H L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis Science 1994, 265:1237-40.
19. Lider O, Santos L M, Lee C S, Higgins P J, Weiner H L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CDS+ T lymphocytes J Immunol 1989; 142:748-52.
20. Hirahara K, Hisatsune T, Nishijima K, Kato H, Shiho O, Kaminogawa S. CD4+ T cells anergized by high dose feeding establish oral tolerance to antibody responses when transferred in SCID and nude mice J Immunol 1995; 154:6238-45.
21. Chen Y, Inobe J, Kuchroo V K, Baron J L, Janeway C A Jr, Weiner H L. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996; 93:388-91.
22. Barone K S, Jain S L, Michael J G. Effect of in vivo depletion of CD4+ and CDS+ cells on the induction and maintenance of oral tolerance. Cell Immunol 1995; 163:19-29.
23. Ke Y, Kapp J A Oral antigen inhibits priming of CDS+ CTL, CD4+ T cells, and antibody responses while activating CDS+ suppressor T cells. J Immunol 1996; 156 916-21
24. Tada Y, Ho A, Koh D R, Mak T W. Collagen-induced arthritis in CD4+ or CD8-deficient mice: CDS+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis J Immunol 1996; 156:4520-6.
25. Chen Y, Inobe J, Weiner H L. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CDS+ cells mediate active suppression. J Immunol 1995; 155:910-6.
26. Vistica B P, Chanaud N P III, Felix N, Caspi R R, Rizzo L V, Nussenblatt R B, et al. CD8 T-cells are not essential for the induction of "low-dose" oral tolerance. Clin Immunol Immunopathol 1996; 78:196-202.
27. Mosmann T R, Subash S. The expanding universe of T cell subsets Th1, Th2 and more Immunol Today 1996; 17:138-46.
28. Daynes R A, Araneo B A, Dowell T A, Huang K, Dudley D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990; 171:979-96.
29. Shull M M, Ormsby I, Kier A B, Pawlowski S, Diebold R J, Yin M, et-al Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 1992; 359:693-9.
30. Fukaura H, Kent S C, Pietrusewicz M J, Khoury S J, Weiner H L, Hafler D A. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996; 98:70-7
31. Desvignes C, Bour H, Nicolas J F, Kaiserlian D. Lack of oral tolerance but oral priming for contact sensitivity to dirutrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice. Eur J Immunol 1996; 26:1756-61.
32. Miller A, Lider O, Weiner H L. Antigen driven bystander suppression following oral administration of antigens J Exp Med 1991; 174:791-8.
33. Al-Sabbagh A, Miller A, Sobel R A, Weiner H L Suppression of PLPinduced EAE in the SJL mice by oral administration of MBP. Neurology 1992;42(suppl 3):346.
34. Harrison L C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 1992; 13:348-52
35. Fujihashi K, Taguchi T, Aicher W K, McGhee J R, Bluestone J A, Eldridge J H, et al Immunoregulatory functions for murine intraepithelial lymphocytes: γδT cell receptor positive (TCR+) T cell abrogate oral tolerance while αβ TCR+ T cell provide B cell help. J Exp Med 1992; 175:695-707.
36. Ke Y, Pearce K, Lake J P, Ziegler H K, Kapp J A. Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 1997; 158:3610-8.
37. Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, Obana S, et al Homeostatic regulation of intestinal epithelial by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 1995; 92:6147-51.
38. Fujihashi K, McGhee J R, Kweon M N, Cooper M D, Tonegawa S, Takahashii I, et al. γδ T cell deficient mice have impaired mucosal IgA responses J Exp Med 1996; 183:1929-35.
39. Zhang Z, Michael J. Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment. J Immunol 1990; 144:4163-5.
40. Vajdy M, Kosco-Vilbois M H, Kopf M, Kohler G, Lycke N. Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 1995; 181:41-53.
41. Garside P, Steel M, Worthey E A, Satoskar A, Alexander J, Bluethmann H J, et al. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. Immunol 1995; 154:5649-55
42. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin transgenic mice. systemic neutralisation of IL-12 augments TGF-b secretion and T cell apoptosis. J Immunol 1996; 157:2348-57.
43. Al-Sabbagh A, Garcia G, Slavin A, Werner H L, Nelson P. Combination therapy with oral myelin basic protein and oral methotrexate enhances suppression of experimental autoimmune encephalomyelitis. Neurology 1997; 48:A421.
44. Sun J B, Rask C, Olsson T, Holmgren J, Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 1996, 93 7196-201
45. Bergerot I, Ploix C, Peterson J, Moulin V, Rask C, Fabien N, et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA 1997; 94:4610-4.
46. Khoury S J, Lider O, Al-Sabbagh A, Werner H L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III Synergistic effect of lipopolysaccharide. Cell Immunol 1990; 131:302-10
47. Karpus W J, Lukacs N W. The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with anti-monocyte chemotactic protein-1. Ann NY Acad Sci 1996; 778:133-44.
48. Blanas E, Carbone F R, Allison J, Miller J F P, Heath W R. Induction of autoimmune diabetes by oral administration of autoantigen. Science 1996; 274:1707-9.
49. Bitar D, Whitacre C C Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell Immunol 1988; 112:364-70.
50. Higgins P, Weiner H L Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988; 140:440-5.
51. Lider O, Santos L M B, Lee C S Y, Higgins P J, Weiner H L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein II Suppression of disease and in vitro immune responses is mediated by antigen specific CDS+ T lymphocytes. J Immunol 1989; 142:748-52.
52. Khoury S J, Hancock W W, Weiner H L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain J Exp Med 1992; 176:1355-64.
53. Al-Sabbagh A, Goad M E P, Weiner H L, Nelson P A. Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 1996; 45:424-9.
54. Chen Y, Inobe J, Kuchroo V K, Baron J L, Janeway C A Jr, Werner H L. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppres-sion of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996; 93:388-91.
55. Thompson H S G, Staines N A. Gastric administration of type II collagen delays onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986; 64:581-6.
56. Thompsom H S G, Harper N, Bevan D J, Staines N A. Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritis responses mediated by active peripheral suppression. Autoimmunity 1993; 16:189-99.
57. Zhang J Z, Lee C S Y, Lider O, Weiner H L. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol 1990; 145:2489-93
58. Yoshino S, Quattrocchi E, Weiner H L. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen. Arthritis Rheum 1995; 38:1092-6.
59. Haque M A, Yoshino S, Inada S, Nomaguchi H, Tokunaga O, Kohashi O, et al Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein. Eur J Immunol 1996; 26:2650-6.
60. Nussenblatt R B, Caspi R R, Mahdi R, Chan C C, Roberge F, Lider O, et al Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990; 144:1689-95.
61. Vrabec T R, Gregerson D S,Dua H S, Donoso L A. Inhibition of experimental autoimmune uveitis by oral administration of S-antigen and synthetic peptide Autoimmunity 1992; 12:175-84.
62. Zhang Z J, Davidson L, Eisenbach G, Weiner H L. Suppression of diabetes in non obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88:10252-6.
63. Bergerot J, Fabien N, Maguer V, Thivolet C. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes. J Autoimmunity 1994; 7:655-63
64. Hancock W W, Polanski M, Zhang Z J, Blogg N, Weiner H L Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol 1995; 147:1193-9.
65. Harrison L C, Demsey-Collier M, Kramer D R, Takahashi K. Aerosol insulin induces regulatory CDS γδT cells that prevent murine insulin-dependent diabetes J Exp Med 1996; 184:2167-74.
66. Daniel D, Wegmann D R. Protection of non obese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 1996; 93:956-60.
67. von Herrath M G, Dyrberg T, Oldstone M B A. Oral insulin treatment suppresses virus-induced antigen specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 1996; 98:1324-31.
68. Weiner H L, Mackin G A, Matsui M, Oray F J, Khoury S J, Dawson D M, et al. Double blind pilot trial of oral tolerisation with myelin antigens in multiple sclerosis. Science 1993; 259:1321-4.
69. Trentham D E, Dynesius-Trentham R A, Oray E J, Combitchi D, Lorenzo C, Sewell K L, et al. Effects of oral administration of collagen on rheumatoid arthritis. Science 1993; 261:1727-30.
70. Fukaura H, Kent S C, Pietrusewicz M J, Khoury S J, Weiner H L, Hafler D A. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-betal-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996; 98:70-77.
71. Autoimmune Inc., Lexington, MA, USA. Internet abstract, http://www.autoimmuneinc.com.
72. Autoimmune Inc., Lexington, MA, USA. Internet abstract. http.//www.autoimmuneinc.com.
73. Nussenblatt R B, Gery I, Weiner H L, Ferris F L, Shiloach J, Remaley N, et al Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial Am J Ophthalmol 1997; 123:583-92.
74. Matsumoto T, Miike T, Ono T. Mite related allergy and oral tolerance Allergy 1996; 551:276-7.
75. Schatz D A, Rogers D G, Brouhard B H. Prevention of insulin-dependent diabetes mellitus: an overview of three trials. Cleve Clin J Med 1996; 63:270-4.
76. Ma S W, Zhao D L, Yin Z Q, Mykherjee R, Singh B, Qin H Y, et al. Transgenic plants expressing autoantigens fed to mice to induce oral tolerance Nat Med 1997; 3:793-6.
77. Prakken B J, van der Zee R, Anderson S M, van Kooten P J S, Kuis W, van Eden W. Peptide induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and non microbially induced experimental arthritis. Proc Natl Acad Sci USA 1997; 94:3284-9.
78. Harper H M, Cochrane L, Williams N A. The role of small intestinal antigen-presenting cells in the induction of T-cell reactivity to soluble protein antigens: association between aberrant presentation in the lamina propria and oral tolerance. Immunology 1996; 89:449-56.
79. Miller A, Lider O, Abramsky O, Weiner H L Orally administered myelin basic protein in neonates primes for immune reponses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur J Immunol 1994; 24:1026-32.
80. Singh R R, Hahn B H, Sercarz E. Neonatal peptide exposure can prime T cells and upon subsequent immunisation induce their immune deviation: implications for antibody vs T cell-mediated autoimmunity. J Exp Med 1996; 183:1613-21
81. Genain C P, Abel K, Belmar N, Villinger F, Rosenberg D P, Linington C, et al. Late complications of immune deviation therapy in non human primate. Science 1996; 274:2054-6.